Stage I NSCLC: elucidating the prognostic factors

Editorial

DuyKhanh Pham et al. Thorax. 2009 Mar.

. 2009 Mar;64(3):185-6.

doi: 10.1136/thx.2008.105965.

No abstract available

Comment on

Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, Wu YC. Hung JJ, et al. Thorax. 2009 Mar;64(3):192-6. doi: 10.1136/thx.2007.094912. Thorax. 2009. PMID: 19252018

Prognostic markers for stage I non-small cell lung cancer.
Mizuguchi S, Nishiyama N. Mizuguchi S, et al. Lung Cancer. 2008 Feb;59(2):274-5. doi: 10.1016/j.lungcan.2007.10.020. Epub 2007 Dec 4. Lung Cancer. 2008. PMID: 18055061 No abstract available.
L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. Imai H, et al. Histopathology. 2009 Jun;54(7):804-13. doi: 10.1111/j.1365-2559.2009.03300.x. Histopathology. 2009. PMID: 19635099
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Al-Shibli K, Al-Saad S, Donnem T, Persson M, Bremnes RM, Busund LT. Al-Shibli K, et al. Histopathology. 2009 Sep;55(3):301-12. doi: 10.1111/j.1365-2559.2009.03379.x. Histopathology. 2009. PMID: 19723145
New TNM classification for non-small-cell lung cancer.
Tanoue LT, Detterbeck FC. Tanoue LT, et al. Expert Rev Anticancer Ther. 2009 Apr;9(4):413-23. doi: 10.1586/era.09.11. Expert Rev Anticancer Ther. 2009. PMID: 19374596 Review.
Treatment of locally advanced non-small cell lung cancer.
Fidler MJ, Kim AW, Zusag T, Bonomi P. Fidler MJ, et al. Clin Adv Hematol Oncol. 2009 Jul;7(7):455-64, 479-80. Clin Adv Hematol Oncol. 2009. PMID: 19701153 Review.